Log in to save to my catalogue

A retrospective analysis of the therapeutic effects of 0.01% atropine on axial length growth in chil...

A retrospective analysis of the therapeutic effects of 0.01% atropine on axial length growth in chil...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8478763

A retrospective analysis of the therapeutic effects of 0.01% atropine on axial length growth in children in a real-life clinical setting

About this item

Full title

A retrospective analysis of the therapeutic effects of 0.01% atropine on axial length growth in children in a real-life clinical setting

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

Journal title

Graefe's archive for clinical and experimental ophthalmology, 2021-10, Vol.259 (10), p.3083-3092

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

More information

Scope and Contents

Contents

Background
Several randomized controlled studies have demonstrated the beneficial effects of 0.01% atropine eye drops on myopia progression in children. However, treatment effects may be different in a routine clinical setting. We performed a retrospective analysis of our clinical data from children to investigate the effect of 0.01% atropine ey...

Alternative Titles

Full title

A retrospective analysis of the therapeutic effects of 0.01% atropine on axial length growth in children in a real-life clinical setting

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8478763

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8478763

Other Identifiers

ISSN

0721-832X

E-ISSN

1435-702X

DOI

10.1007/s00417-021-05254-5

How to access this item